Cumberland Pharmaceuticals (CPIX) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$0.13.
- Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) fell 1818.18% to -$0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.24, marking a year-over-year increase of 6883.12%. This contributed to the annual value of -$0.46 for FY2024, which is 415.74% down from last year.
- According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) is -$0.13, which was down 1818.18% from -$0.05 recorded in Q2 2025.
- Cumberland Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at $0.08 for Q2 2021, and its period low was -$0.44 during Q4 2023.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.09, with a median of -$0.09 in 2022.
- Per our database at Business Quant, Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) surged by 17272.73% in 2021 and then plummeted by 128541.15% in 2024.
- Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.29 in 2021, then surged by 41.38% to -$0.17 in 2022, then plummeted by 159.26% to -$0.44 in 2023, then surged by 69.31% to -$0.14 in 2024, then increased by 3.88% to -$0.13 in 2025.
- Its last three reported values are -$0.13 in Q3 2025, -$0.05 for Q2 2025, and $0.08 during Q1 2025.